Prodotto aggiunto correttamente al carrello.

discount label
H-YMLDL^QPETT-OH
Visualizzare in 3D

Biosynth logo

H-YMLDL^QPETT-OH

Rif. 3D-PP43487

Dimensione non definitaPrezzo su richiesta
Consegna stimata in Stati Uniti, il Giovedì 12 Dicembre 2024

Informazioni sul prodotto

Nome:
H-YMLDL^QPETT-OH
Sinonimi:
  • NH2-Tyr-Met-Leu-Asp-Leu^Gln-Pro-Glu-Thr-Thr-OH
Descrizione:

Peptide H-YMLDL^QPETT-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YMLDL^QPETT-OH include the following: T lymphocytes derived from human cord blood provide effective antitumor immunotherapy against a human tumor YS Lee, TS Kim, DK Kim - BMC cancer, 2011 - Springerhttps://link.springer.com/article/10.1186/1471-2407-11-225 Presentation of lipopeptide by dendritic cells induces anti-tumor responses via an endocytosis-independent pathway in vivo YC Song , AH Chou, A Homhuan - Journal of Leukocyte , 2011 - academic.oup.comhttps://academic.oup.com/jleukbio/article-abstract/90/2/323/6960320 Generation of tumor-specific cytotoxic T lymphocytes by stimulation with HPV type 16 E7 peptide-pulsed dendritic cells: an approach to immunotherapy of cervical WMJ Schoell, R Mirhashemi, B Liu, MF Janicek - Gynecologic , 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S009082589995504X Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial WJ Van Driel, ME Ressing, GG Kenter - European journal of , 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0959804999000489 Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations WF Cheng, CN Lee, YN Su, MC Chang - , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2005.02126.x Linear epitope prediction in HPV type 16 E7 antigen and their docked interaction with human TMEM 50A structural model U Srivastava , S Singh, B Gautam , P Yadav - , 2017 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498776/ Use of fluorogenic histocompatibility leukocyte antigen-A* 0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous SJ Youde, PRR Dunbar , EML Evans, AN Fiander - Cancer research, 2000 - AACRhttps://aacrjournals.org/cancerres/article-abstract/60/2/365/506850 Cross-typic specificity and immunotherapeutic potential of a human HPV16 E7-specific CTL line SJ Youde, CM McCarthy, KJ Thomas - Journal of Cancer, 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.20779 A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo SH Tu, HI Huang , SI Lin, HY Liu, YP Sher - Journal of , 2012 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/FullText/2012/04000/A_Novel_HLA_A2_restricted_CTL_Epitope_of.4.aspx Study on phenotype and function of antigen-specific CD8+ cytotoxic T cells induced by HPV 16 E7 peptide in vitro. QQF Qian QiFeng, LFG Li FangGu, LQ Li Qing - 2010 - cabidigitallibrary.orghttps://www.cabidigitallibrary.org/doi/full/10.5555/20103227892 detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic N Cools , P Ponsaerts , M Lenjou, G Nijs - Molecular Cancer, 2006 - Springerhttps://link.springer.com/article/10.1186/1476-4598-5-49 A single amino acid substitution improves the in vivo immunogenicity of the HPV16 oncoprotein E7 (11-20) cytotoxic T lymphocyte epitope MWJ Schreurs, EWM Kueter, KBJ Scholten - Vaccine, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X05003804 Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway ML Mora-Garcaca­a , LR acavila-Ibarra, R Garcaca­a-Rocha - Cellular , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874917301363 Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone ML Mora-Garcaca­a , A Duenas-Gonzalez - Journal of Translational , 2006 - Springerhttps://link.springer.com/article/10.1186/1479-5876-4-55 Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions M de Lourdes Mora-Garcaca­a , R Garcaca­a-Rocha - Journal of Translational , 2016 - Springerhttps://link.springer.com/article/10.1186/s12967-016-1057-8 Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type M Alexander, ML Salgaller, E Celis, A Sette - American journal of , 1996 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0002937896701102 Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein K Nilges, H Höhn, H Pilch, C Neukirch - Journal of , 2003 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.77.9.5464-5474.2003 Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization HW Chen, CH Leng, HY Liu, WF Cheng - Cancer Biology & , 2009 - Taylor & Francishttps://www.tandfonline.com/doi/pdf/10.4161/cbt.8.21.9732 Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A* 0201-restricted T-cell peptides in cervical cancer patients DW Liu, YC Yang, HF Lin, MF Lin, YW Cheng - Journal of , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02256-06 Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens DB Keskin , B Reinhold , SY Lee, G Zhang - Frontiers in , 2011 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2011.00075/full Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations. CWF Cheng WenFang, LCN Lee ChienNan - 2005 - cabidigitallibrary.orghttps://www.cabidigitallibrary.org/doi/full/10.5555/20053066734 Activated B cells mediate efficient expansion of rare antigen-specific T cells C Zentz, M Wiesner, S Man, B Frankenberger - Human immunology, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0198885906006112 Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy C Thornburg, D Boczkowski, E Gilboa - Journal of , 2000 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2000/07000/induction_of_cytotoxic_t_lymphocytes_with.4.aspx A Promising New Model: Establishment of Patient-Derived Organoid Models Covering HPV-Related Cervical Pre-Cancerous Lesions and Their Cancers B Hu, R Wang, D Wu, R Long, J Fan, Z Hu - Advanced , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/advs.202302340 Molecular characterization of antigen-peptide pulsed dendritic cells: immature dendritic cells develop a distinct molecular profile when pulsed with antigen peptide AX Yang, N Chong, Y Jiang, J Catalano, RK Puri - PloS one, 2014 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0086306

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP43487 H-YMLDL^QPETT-OH

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".